Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.570
-0.130 (-2.77%)
At close: Oct 23, 2026, 4:00 PM EDT
4.580
+0.010 (0.22%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Nuvation Bio Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Nuvation Bio stock has a consensus rating of "Strong Buy" and an average price target of $13. The average 1-year stock price forecast is 184.46% higher than the current stock price, while the lowest is $7.00 (+53.17%) and the highest is $21 (+359.52%).
Price Target: $13 (+184.46%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nuvation Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 8 | 9 | 9 |
| Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 12 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst UBS No rating | UBS | Hold Maintains $7 | Hold | Maintains | $7 | +53.17% | Oct 20, 2026 |
| Citi | Citi | Buy Maintains $12 | Buy | Maintains | $12 | +162.58% | Oct 16, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $20 | Buy | Maintains | $20 | +337.64% | Oct 12, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $11 | Buy | Maintains | $11 | +140.70% | Sep 15, 2026 |
Financial Forecast
Revenue This Year
194.60M
from 62.90M
Increased by 209.36%
Revenue Next Year
275.55M
from 194.60M
Increased by 41.60%
EPS This Year
-0.29
from -0.49
EPS Next Year
-0.02
from -0.29
EPS and Forward PE are based on non-GAAP adjusted numbers.